| abstract |
The invention relates to a combination of at least two therapeutic combinati on components selected from the group consisting of (i) an AT1-receptor antagonist or an AT1 receptor antagonist combined with a diuretic or, in eac h case, a pharmaceutically acceptable salt thereof, (ii) a HMG-Co-A reductase inhibitor or a pharmaceutically acceptable salt thereof and (iii) an ACE inhibitor or a pharmaceutically acceptable salt thereof for use in the prevention of, delay of progression of, treatment of selected diseases and conditions. |